Invivoscribe is a global, vertically integrated biotechnology company dedicated to Improving Lives with Precision Diagnostics^®. For more than thirty years, Invivoscribe has advanced the quality of healthcare worldwide by delivering high-quality, standardized reagents, diagnostic assays, and bioinformatics solutions that support precision medicine. The company has a proven track record of partnering with pharmaceutical and biotechnology organizations to support clinical trial testing through its global laboratory network in the United States, Germany, Japan, and China, as well as to develop and commercialize companion diagnostics, leveraging deep expertise in regulatory strategy and laboratory services. By offering both distributable diagnostic kits and clinical testing services through its globally located clinical laboratory subsidiaries, LabPMM^®, Invivoscribe is an ideal partner across the full diagnostic lifecycle – from development and clinical trials through regulatory submission and commercialization.